ChemicalBook

ANTI-INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (TYPE-I)

 структура
CAS №
английское имя:
ANTI-INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (TYPE-I)
Синонимы:
ANTI-IP3R-I;IP3 RECEPTOR TYPE I;ANTI-IP3 RECEPTOR (TYPE-I);ANTISERUM TO INS(1,4,5)P3, RECEPTOR TYPE I;ANTI-INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR (TYPE I);ANTI-INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (TYPE-I);POLYCLONAL ANTIBODY TO INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR TYPE I;Anti-Inositol 1,4,5-Triphosphate Receptor (Type I) antibody produced in rabbit
CBNumber:
CB5418338
Формула:
молекулярный вес:
0
MOL File:
Mol file

ANTI-INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (TYPE-I) атрибут

температура хранения: −20°C
форма: буферный водный раствор
Биологические источники: rabbit
UNSPSC Code: 12352203

Заявления о рисках и безопасности

WGK Германия -

ANTI-INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (TYPE-I) химические свойства, назначение, производство

Общее описание

The gene ITPR1 (inositol 1,4,5-triphosphate receptor type 1) encodes an intracellular receptor that binds to inositol 1,4,5 trisphosphate. It is localized to membranes of endoplasmatic or sarcoplasmatic (in muscle cells) reticulum. The gene is mapped to human chromosome 3p26.

Биохимия/физиол Действия

The ligand-gated calcium channel encoded by the gene ITPR1 (inositol 1,4,5-triphosphate receptor type 1) is stimulated upon binding to its ligand inositol 1,4,5-triphosphate, and mediates intracellular calcium signaling. It facilitates the release of Ca2+ from endoplasmic reticulum and modulates intracellular Ca2+ concentration. This is a crucial mechanism in the initial stages of myoblast differentiation. Mutations in this gene have been associated with sporadic infantile-onset cerebellar ataxia.

ANTI-INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (TYPE-I) препаратная продукция и сырье

сырьё

препарат


ANTI-INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (TYPE-I) поставщик

Global( 8)Suppliers
поставщик телефон страна номенклатура продукции благоприятные условия
Merck KGaA 21-20338288
China 6394 58
Copyright 2017 © ChemicalBook. All rights reserved